Disease Burden of Herpes Zoster in China: A Meta-analysis and Evidence Quality Assessment

Author:

Zhang Zhujiazi1,Liu Xinnong2,Suo Luodan1,Pan Jingbin3,Zhao Dan1,Lu Li1

Affiliation:

1. Beijing Center for Disease Prevention and Control

2. Beijing Tian Tan Hospital

3. Beijing Research Center for Preventive Medicine

Abstract

Abstract Background: This review aimed to estimate the disease burden of herpes zoster (HZ) in China and explore the application of the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) approach in observational studies of disease incidence. Methods: We searched for the literature for observational studies analysing HZ incidence in populations of all ages in China and assessed the quality of each study using the guidelines for the evaluation of incidence studies. Meta-analysis models were constructed to calculate the pooled incidence of HZ and pooled risks of postherpetic neuralgia (PHN), HZ recurrence, and hospitalisation. The studies were divided into subgroups according to sex, age, and quality assessment score and analysed. The quality of evidence for incidence was rated using the GRADE system. Results: Twelve studies with a total of 25,928,408 participants were included in this meta-analysis. The pooled incidence for all ages was 4.28‰ (95% confidence interval [CI]: 1.22–7.35). It increased by age group and increased significantly in those aged ≥60 years, which was 11.69‰ (95% CI: 6.56–16.81). The pooled risks of PHN, recurrence, and hospitalisation were 12.6% (95% CI: 10.1–15.1), 9.7% (95% CI: 3.2–16.2) and 6.0/100,000 population (95% CI: 2.3–14.2), respectively. The quality of the evidence assessment of the pooled incidence for all ages was ‘very low’, which was rated down by one category in limitations and one category in publication bias, with no categories rating it up. The result of the quality of evidence assessment for the ≥60 years old subgroup was ‘low’. Conclusions: HZ is a serious public health problem in China and is more significant in individuals older than 60 years. Therefore, an immunisation strategy for the zoster vaccine should be considered. The GRADE approach can be applied to the rating quality of evidence in disease incidence studies, but the process needs to be more specific and operable.

Publisher

Research Square Platform LLC

Reference60 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3